Download PDF
Thromb Haemost 1992; 67(03): 320-324
DOI: 10.1055/s-0038-1648440
Original Articles
Schattauer GmbH Stuttgart

Absence of the Largest Platelet-von Willebrand Multimers in a Patient with Lactoferrin Deficiency and a Bleeding Tendency

Robert I Parker
The Hematology Service, Clinical Pathology Department, Clinical Center, Bethesda, MD, USA
,
Laurie P McKeown
The Hematology Service, Clinical Pathology Department, Clinical Center, Bethesda, MD, USA
,
John I Gallin
*   Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
,
Harvey R Gralnick
The Hematology Service, Clinical Pathology Department, Clinical Center, Bethesda, MD, USA
› Author Affiliations
Further Information

Publication History

Received 31 May 1991

Accepted after revision 09 October 1991

Publication Date:
03 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

We have studied a young male with lactoferrin deficiency and a bleeding tendency responsive to cryoprecipitate. This child has had increased bleeding following surgical procedures and a variably prolonged template bleeding time. The patient has a normal platelet count, normal in vitro platelet ATP secretion and aggregation in response to a variety of agonists, and normal concentration of plasma-von Willebrand factor ristocetin cofactor activity and antigen. Analysis of plasma-vWf multimers by agarose gel electrophoresis consistently demonstrated a subtle decrease in the largest vWf multimers. In contrast, analysis of the patient’s platelet-vWf revealed normal vWf:Ag, decreased vWf ristocetin cofactor activity, and a striking absence of the high and intermediate size molecular weight vWf multimers. Analysis of surface bound platelet-vWf demonstrated normal amounts on the surface of unstimulated platelets, but after thrombin stimulation the platelet-vWf surface expression did not increase. This lack of increased platelet-vWf surface expression resulted from decreased binding of secreted platelet-vWf to be surface of stimulated platelets. These data suggest that the patient’s bleeding tendency may be related to a defect in his platelet-vWf structure and/or mobilization. This case represents a unique demonstration of an abnormality of platelet-vWf in the presence of normal plasma-vWf, and supports the data indicating an important role for platelet-vWf in primary hemostasis.

 

  • References

  • 1 Howard MA, Montgomery DC, Hardisty RM. Factor-VlII-related antigen in platelets. Thromb Res 1974; 4: 617-624
    CrossrefPubMedGoogle Scholar
  • 2 Nachman RL, Jaffe EA. Subcellular platelet factor VIII antigen and von Willebrand factor. J Exp Med 1975; 141: 1101-1113
    CrossrefPubMedGoogle Scholar
  • 3 Slot JN, Bouma BN, Montgomery R, Zimmerman TS. Platelet factor Vll-related antigen: Immunofluorescent localization. Thromb Res 1978; 13: 871-881
    CrossrefPubMedGoogle Scholar
  • 4 Flaum MA, Donlon JA, Gralnick HR, Rick ME. The identification and functional significance of factor VIII components on normal platelets. Thromb Res 1982; 26: 165-175
    CrossrefPubMedGoogle Scholar
  • 5 Jenneau C, Sultan Y. Immunocytochemical localization of factor VIII/ von Willebrand factor antigen in human platelets. Bio Cell 1983; 49: 237-242
    PubMedGoogle Scholar
  • 6 Wencel-Drake JD, Painter RG, Zimmerman TS, Ginsberg MH. Ultrastructural localization of human platelet thrombospondin, fibrinogen, fibronectin, and von Willebrand factor in frozen thin section. Blood 1985; 65: 929-938
    CrossrefPubMedGoogle Scholar
  • 7 Parker RI, Shafer BC, Gralick HR. Platelet density-dependent partition of platelet-von Willebrand factor between alpha granule and non-alpha granule pools. Thromb Haemostas 1987; 58: 911-914
    PubMedGoogle Scholar
  • 8 Zucker MB, Broekman MJ, Kaplan KL. Factor Vll-related antigen in human platelets. Localization and release by thrombin and collagen. J Lab Clin Med 1979; 94: 675-682
    PubMedGoogle Scholar
  • 9 Koutts J, Walsh PN, Plow EF, Fenton JW, Bouma HNN, Zimmerman TS. Active release of human platelet factor VUI-related antigen by adenosine diphosphate, collagen and thrombin. J Clin Invest 1978; 62: 1255-1263
    CrossrefPubMedGoogle Scholar
  • 10 Sultan Y, Maisonneuve P, Angles-Cano E. Release of VIIIR: Ag and VIIIR:WF during thrombin and collagen induced aggregation. Thromb Res 1979; 15: 415-425
    CrossrefPubMedGoogle Scholar
  • 11 Wencel-Drake JD, Plow EF, Zimmerman TS, Painter RG, Ginsberg MH. Immunofluorescent localization of adhesive glycoproteins in resting and thrombin-stimulated platelets. Am J Pathol 1984; 115: 156-164
    PubMedGoogle Scholar
  • 12 George JN, Onofre AR. Human platelet surface binding of endogenous secreted factor VIII-von Willebrand factor and platelet factor 4. Blood 1982; 59: 194-197
    PubMedGoogle Scholar
  • 13 Fernandez MFL, Ginsberg MH, Ruggeri ZM, Batlle FJ, Zimmerman TS. Multimeric structure of platelet factor VIII/von Willebrand factor: The presence of larger multimers and their reassociation with thrombin-stimulated platelets. Blood 1982; 60: 1132-1138
    PubMedGoogle Scholar
  • 14 Parker RI, Rick ME, Gralnick HR. Effect of calcium on the availability of platelet von Willebrand factor. J Lab Clin Med 1985; 106: 336-342
    PubMedGoogle Scholar
  • 15 Weiss HJ, Turitto VT, Baumgartner HS. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate-dependent decrease of adhesion in von Willebrand’s disease and Bernard-Soulier syndrome. J Clin Invest 1978; 92: 750-764
    PubMedGoogle Scholar
  • 16 Baumgartner HS, Tshopp TB, Meyer D. Shear rate dependent inhibition of platelet adhesion and aggregation on collagenous surfaces by antibodies to human factor VIII/von Willebrand factor. Br J Haematol 1980; 44: 127-139
    CrossrefPubMedGoogle Scholar
  • 17 Stel HV, Sakariassen KS, de Groot PG, van Mourik JA, Sixma JJ. Von Willebrand factor in vessel wall mediates platelet adherence. Blood 1985; 65: 85-90
    PubMedGoogle Scholar
  • 18 Turitto VT, Weiss HJ, Zimmerman TS. Sussman II. Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion. Blood 1985; 65: 823-831
    PubMedGoogle Scholar
  • 19 Gralnick HR, Williams SB, McKeown LP, Krizek DM, Shafer BS, Rick ME. Platelet von Willebrand factor: Comparison with plasma von Willebrand factor. Thromb Res 1985; 38: 623-633
    CrossrefPubMedGoogle Scholar
  • 20 Corash L, Costa JL, Shafer B, Donlon JA, Murphy D. Heterogeneity of human whole blood platelet subpopulations. III. Density-dependent differences in subcellular constituents. Blood 1984; 64: 185-193
    PubMedGoogle Scholar
  • 21 Detwiler TC, Feinman RD. Kinetics of the thrombin-induced release of adenosine triphosphate by platelets. Comparison with release of calcium. Biochemistry 1973; 12: 2462-2468
    CrossrefPubMedGoogle Scholar
  • 22 White JG, Sauk JJ. The organization of microtubules and microtubule coils in giant platelet disorders. Am J Pathol 1984; 116: 514-522
    PubMedGoogle Scholar
  • 23 Gallin JI, Fletcher MP, Seligmann BE, Hoffstein S, Cehrs K, Mounessa N. Human neutrophil-specific granule deficiency: A model to assess the role of neutrophil-specific granules in the evolution of the inflammatory response. Blood 1982; 59: 1317-1329
    PubMedGoogle Scholar
  • 24 Mannucci PM, Lombardi R, Bader R, Vianello L, Federici AB, Solinas S, Mazzucconi MG, Mariani G. Heterogeneity of Type I von Willebrand’s disease: Evidence for a subgroup with an abnormal von Willebrand factor. Blood 1985; 66: 796-802
    PubMedGoogle Scholar
  • 25 Gralnick HR, Rick ME, McKeown LP, Williams SB, Parker RI, Maisonneuve P, Jenneau C, Sultan Y. Platelet von Willebrand factor: An important determinant of the bleeding time in Type I von Willebrand’s disease. Blood 1986; 68: 58-61
    PubMedGoogle Scholar
  • 26 Bowie EJW, Solberg jr LA, Fass DN, Johnson CM, Knutson GJ, Stewart ML, Zoecklin LJ. Transplantation of normal bone marrow into a pig with severe von Willebrand’s disease. J Clin Invest 1986; 78: 26-30
    CrossrefPubMedGoogle Scholar
  • 27 Castillo R, Escolar G, Monteagudo J, Ordinas A, Garrido M, Moia M, Federici AB, Mannucci PM. Role for platelet von Willebrand factor in supporting platelet-vessel wall interactions in von Willebrand disease. Am J Hematol 1989; 31: 153-158
    CrossrefPubMedGoogle Scholar
  • 28 Drouin J, Lillicrap DP, Izaguirre CA, Sutherland M, Windsor S, Benford K, Hoogendorn H, Giles AR. Absence of a bleeding tendency in severe acquired von Willebrand’s disease. The role of platelet von Willebrand factor in maintaining normal hemostasis. Am J Clin Pathol 1989; 92: 471-478
    CrossrefPubMedGoogle Scholar
  • 29 Hoy er LW, Rizza CR, Tuddenham EGD, Carta CA, Armitage H, Rotblat F. Von Willebrand factor multimer patterns in von Willebrand’s disease. Br J Haematol 1983; 55: 493-507
    CrossrefPubMedGoogle Scholar